recent articles
Immunoscore® Colon is the first standardized immune‐based assay for the classification of cancers Immunoscore® has been validated by the Immunoscore® worldwide consortium, led by the SITC (ASCO 2016) Immunoscore® is a...
April 16, 2015, Westminster CO — Flagship Biosciences, the leading service provider of digital pathology solutions, announced today the utilization of its wet assay development and image analysis quantification capabilities for RNAscope®...
Accuracy of HER2 Testing in Gastric Cancer
- Anatomic Pathology
- Business
- Clinical Laboratories
- Current Affairs
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- Genetics
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Medical Research
- Pathology News
- Patient Advocacy
- Science
- Standards and Guidelines
- Training
- Vendor products
- Web/Tech
- Webinars
- Whole slide
With almost 1 million new cases per year, gastric cancer is currently the number four most common malignant disease. Today, there is no universal standard treatment. Recently, however, the ToGA trial demonstrated efficacy of Trastuzumab...
Visit Definiens at booth #423 at the Molecular Med-Tri-Con conference, February 16-18 to learn about Definiens’ comprehensive range of digital and molecular pathology solutions for imaging and quantifying biomarkers in tissue sections. At...
Carlsbad, CA. - January 21, 2015 - Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its GenASIs HiPath image capture and analysis...
Join Applied Spectral Imaging at CAP’14 – THE Pathologists’ Meeting...
Join ASI in booth # 223 at CAP’14 – THE Pathologists’ Meeting Come see ASI’s GenASIs HiPath, the latest Pathology Quantitative Diagnostic Aid, providing solutions for any sized lab! Ask questions from our experts, see a demo and get...